Search

everythinglearnresearchcommunity

for

Search:↓

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Changing CDK4 levels affects the number of stem cells in mouse hair follicles.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Tislelizumab can cause cutaneous lupus erythematosus.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

3D spheroid culture makes stem cells better at reducing inflammation.

CS12192 effectively treats alopecia areata with better safety than current options.

Human thymus has stem cells that can self-renew and maintain their identity.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

PCFCL may have unrecognized subtypes and needs more research.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Finasteride increases CD8+ T cells in BPH tissues.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.